Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy
Year: 2025
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Mark B. Meads, Xiaohong Zhao, David Noyes, Praneeth R. Sudalagunta, Alexandra Achille, Chaomei Zhang, Rafael R. Canevarolo, Maria Silva, Dario Magaletti, Daniel DeAvila, Sonila Toska, Ashley Oates, Daniel Lastorino, Dietrich Werner Idiaquez, Jinming Song, Samer S. Sansil, Sean J. Yoder, Ariel F. Grajales-Cruz, Brandon Blue, Ciara L. Freeman, Jongphil Kim, Melissa Alsina, Jason Brayer, Ariosto S. Silva, Xiaofei Song, Kenneth H. Shain, Rachid Baz
Institution: Moffitt Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414398026